Bariatric surgery: a successful therapeutic option
DOI:
https://doi.org/10.47196/diab.v52i3.126Keywords:
bariatric surgery, triglycerides, obesity, hdl-cholesterolAbstract
The bariatric surgery is, until now, the most effective treatment for the management of people with severe or morbid obesity, which is considered with a body mass index (BMI) >40 or >35 when overweight is accompanied by metabolic disease.
The most used surgical procedures are the bypass in Y of Roux (BP) and the sleeve or gastric sleeve (GS), which are generally safe and effective. They produce a significant decrease in weight in the short and medium term (between six months and a year), and reduce the morbidity and mortality of patients with improved metabolic alterations. In a large percentage of cases remission is observed.
References
Feng T, Vegard M, Strand L, et al. Metabolically healthy obesity and risk for atrial fibrillation: the HUNT Study. Obesity 2019; 27,332-338.
Bays HE, Jones PH, Jacobson TA, Cohen DE, Orringer CE, Kothari S, Azagury DE, Morton J, Nguyen NT, Westman EC, Horn DB, Scinta W, Primack C. Lipids and bariatric procedures part 1 of 2: scientific statement from the National Lipid Association, American Society for Metabolic and Bariatric Surgery, and Obesity Medicine Association. J Clin Lipidol 2016; 10: 33-57.
Bays HE, Kothari SN, Azagury DE, Morton JM, Nguyen NT, Jones PH, Jacobson TA, Cohen DE, Orringer C, Westman EC, Horn DB, Scinta W, Primack C. Lipids and bariatric procedures part 2 of 2: scientific statement from the American Society for Metabolic and Bariatric Surgery, the National Lipid Association and Obesity Medicine Association (OMA). Surg Obes Relat Dis 2016; 12: 468-495.
Buchwald H, Moore RB, Varco RL. Surgical treatment of hyperlipidemia. 3. Clinical status of the partial ileal bypass operation. Circulation 1974; 49:I22-37.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Dirección Nacional de Derecho de Autor, Exp. N° 5.333.129. Instituto Nacional de la Propiedad Industrial, Marca «Revista de la Sociedad Argentina de Diabetes - Asociación Civil» N° de concesión 2.605.405 y N° de disposición 1.404/13.
La Revista de la SAD está licenciada bajo Licencia Creative Commons Atribución – No Comercial – Sin Obra Derivada 4.0 Internacional.
Por otra parte, la Revista SAD permite que los autores mantengan los derechos de autor sin restricciones.
